| Title : Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease - Sychev_2020_Drug.Metab.Pers.Ther_35_ |
| Author(s) : Sychev D , Skripka A , Ryzhikova K , Bochkov P , Shevchenko R , Krupenin P , Ivashchenko D , Kogay V , Listratov A , Krainyaya A , Gurinovich O , Sokolova A , Napalkov D , Fomin V |
| Ref : Drug Metab Pers Ther , 35 : , 2020 |
| Abstract : Sychev_2020_Drug.Metab.Pers.Ther_35_ |
| ESTHER : Sychev_2020_Drug.Metab.Pers.Ther_35_ |
| PubMedSearch : Sychev_2020_Drug.Metab.Pers.Ther_35_ |
| PubMedID: 32134727 |
Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V (2020)
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease
Drug Metab Pers Ther
35 :
Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V (2020)
Drug Metab Pers Ther
35 :